One more reason to avoid mortgage life insurance – and a few exceptions to the rule

The article argues mortgage life insurance is usually inferior to independent term life insurance, citing a hypothetical healthy 40-year-old couple with a $600,000 mortgage paying just over $180/month for mortgage insurance versus less than $89/month combined for two 20-year term policies. It highlights key drawbacks: constant premiums despite shrinking coverage, cancellation on refinancing, payout to the bank rather than the family, and potential claim denial due to post-claim underwriting. Exceptions noted include smokers and some uninsurable borrowers with pre-existing conditions.

Analysis

The bigger market implication is not the retail-product critique itself, but the widening gap between bank-distributed insurance and independent, advice-led term products. That is a slow-burn headwind for Canadian bank cross-sell economics: mortgage origination still captures the customer, but the attach-rate on ancillary insurance becomes more vulnerable when price transparency rises and refinancing mobility stays high. For CM specifically, the article is neutral to slightly negative on fee income quality rather than balance-sheet risk; the issue is that insurance is one of the stickier, higher-margin pieces of the mortgage ecosystem.

Second-order, the product logic reinforces a broader consumer shift toward unbundling financial services. Households that are already rate-shopping mortgages are likely to extend that behavior to insurance, favoring brokerage and direct writers with simplified underwriting and portable contracts. That creates incremental share opportunity for independent life carriers and brokers, while banks face a structural challenge: they own the distribution moment but not necessarily the best economics for the customer.

The key risk to the bearish read is that this is more a conversion-friction story than a demand destruction story. Mortgage life insurance is often purchased at origination when attention is low; if housing activity rebounds, bank sales can still grow in absolute terms even if the product remains inferior on value. The real catalyst is regulatory or advisor-led disclosure pressure over the next 6-18 months, which could materially improve comparison-shopping and shift economics away from the banks faster than the market expects.

Contrarian view: the article may overstate the danger to banks if investors assume insurance is a meaningful profit engine rather than a modest ancillary. The more actionable takeaway is not to short the banks broadly, but to isolate which names have the highest mortgage-insurance attach rate and weakest product economics. That makes this a relative-value issue within Canadian financials, not a thesis on credit quality or mortgage growth.

Key Decisions for Investors

• Reduce exposure to CM on any mortgage-refi or home-sales strength over the next 1-3 months; treat this as a modest fee-mix headwind rather than a core earnings risk, but expect lower ancillary monetization if rate competition stays intense.
• Pair trade: long select independent life/insurance distribution names vs short Canadian banks with larger retail mortgage franchises over a 3-6 month horizon; the relative winner should be the lower-cost, portable-term model as consumer price awareness improves.
• If available in the book, buy downside protection on CM with 6-12 month puts rather than outright shorting; the thesis is a gradual erosion in cross-sell economics, not a near-term earnings shock, so convexity is preferred over linear beta.
• Watch for disclosure or consumer-protection headlines in Canada over the next 6-18 months; those are the catalysts most likely to re-rate bank ancillary revenue assumptions and widen the valuation gap versus advisors/brokers.
• Do not express this as a broad financials short: the risk/reward is poor unless mortgage activity rolls over. The better trade is a relative-value basket tied to insurance distribution economics.